SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today ...
The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.
“FDA’s proposed rule, ‘Use of Formaldehyde and Formaldehyde-Releasing Chemicals as an Ingredient in Hair Smoothing Products ...
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the ongoing research and efforts at the FDA to find ...
Food and Drug Administration Commissioner Dr. Marty Makary joins ‘Fox & Friends’ to discuss updated dietary guidelines ...
New guidelines for healthy eating say Americans should eat more whole foods and protein, fewer highly processed foods and ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical ...
The Beltway-based biopharma disputed the FDA’s conclusions regarding the data provided in its supplemental application for ...
GlobalData on MSN
Octapharma receives FDA approval for new Fibryga formulation in AFD
Octapharma has received approval from the US Food and Drug Administration (FDA) for a new 2-gram (g) formulation of Fibryga ...
The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback